论文部分内容阅读
如今养生保健节目很火,里面某些“专家”建议所有老年朋友服用小剂量阿司匹林,说有病治病,无病强身。但事实是要科学认识疾病和药物,不要道听途说,以偏概全。近几年,阿司匹林在一级预防的地位已经有所降低。所谓一级预防,即患者存在危险因素,但还未发病。2014年日本一级预防项目研究发现,每日服用小剂量阿司匹林,并不能使心血管疾病的低危和中危人群明显获益。美国FDA综合了大量的研究数据后,也不推荐阿司匹林
Now health care programs are very hot, some of which “experts” suggest that all elderly friends take low-dose aspirin, that sick to cure, disease-free and physical. However, the fact is that we must scientifically know the diseases and drugs and do not hesitate to prejudice them. In recent years, the status of aspirin in primary prevention has decreased. The so-called primary prevention, that is, patients with risk factors, but not yet. A 2014 Japanese primary prevention study found that daily administration of low-dose aspirin did not significantly benefit low- and middle-risk people with cardiovascular disease. The United States FDA combined with a large number of research data, do not recommend aspirin